QARS1 Gene

Name glutaminyl-tRNA synthetase 1
Description Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. In metazoans, 9 aminoacyl-tRNA synthetases specific for glutamine (gln), glutamic acid (glu), and 7 other amino acids are associated within a multienzyme complex. Although present in eukaryotes, glutaminyl-tRNA synthetase (QARS) is absent from many prokaryotes, mitochondria, and chloroplasts, in which Gln-tRNA(Gln) is formed by transamidation of the misacylated Glu-tRNA(Gln). Glutaminyl-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nQARS1 encodes glutaminyl-tRNA synthetase (GlnRS), an essential enzyme that catalyzes the attachment of glutamine to its cognate tRNA, thereby underpinning mRNA translation. In the developing human brain, QARS1 is highly expressed and plays a crucial role in neurodevelopment; mutations in this gene have been linked to progressive microcephaly, severe seizures, and cerebral as well as cerebellar atrophy, highlighting its importance in neuronal survival and brain morphogenesis. The reported mutations disrupt highly conserved residues—some located in the N‐terminal domain responsible for interactions within the multisynthetase complex, and others within the catalytic core—resulting in markedly reduced aminoacylation activity and altered protein stability."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nAnother study identified compound heterozygous mutations in QARS1 in patients with early‐onset epileptic encephalopathy (EOEE). In these cases, one mutation (p.Tyr57His) represents a loss‐of‐function missense change, while a novel frameshift mutation (p.Lys496*) produces a truncated protein lacking portions of the catalytic and the entire anticodon-binding domains. These mutations, by impairing the enzyme’s aminoacylation capacity and promoting aberrant aggregation, underscore that defective glutaminyl-tRNA synthetase activity is a key pathological mechanism underlying EOEE and related neurodevelopmental disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nStructural analyses of the intact QARS1 protein have provided further insight into how pathological mutations induce brain disorders. Crystallographic studies delineated the domain organization of human GlnRS, revealing the intricate architecture of its N-terminal domain (NTD), which is essential for proper protein folding and interactions with other components of the multisynthetase complex. Mutations affecting the NTD have been shown to distort its structure, leading to compromised catalytic efficiency and reduced stability, whereas alterations in the catalytic domain promote enzyme misfolding. These findings collectively suggest that both diminished enzymatic function and protein misfolding contribute to the spectrum of neurological abnormalities associated with QARS1 mutations."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}]}]}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xiaochang Zhang, Jiqiang Ling, Giulia Barcia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2014.03.003"}], "href": "https://doi.org/10.1016/j.ajhg.2014.03.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24656866"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24656866"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Hirofumi Kodera, Hitoshi Osaka, Mizue Iai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in the glutaminyl-tRNA synthetase gene cause early-onset epileptic encephalopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hum Genet (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jhg.2014.103"}], "href": "https://doi.org/10.1038/jhg.2014.103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25471517"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25471517"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jana Ognjenović, Jiang Wu, Doreen Matthies, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The crystal structure of human GlnRS provides basis for the development of neurological disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkw082"}], "href": "https://doi.org/10.1093/nar/gkw082"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26869582"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26869582"}]}]}]}
NCBI Gene ID 5859
API
Download Associations
Predicted Functions View QARS1's ARCHS4 Predicted Functions.
Co-expressed Genes View QARS1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View QARS1's ARCHS4 Predicted Functions.

Functional Associations

QARS1 has 1,789 functional associations with biological entities spanning 5 categories (chemical, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 36 datasets.

Click the + buttons to view associations for QARS1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of QARS1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of QARS1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of QARS1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations 2025 phenotypes associated with QARS1 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of QARS1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
CM4AI U2OS Cell Map Protein Localization Assemblies assemblies containing QARS1 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing QARS1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing QARS1 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with QARS1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving QARS1 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with QARS1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with QARS1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with QARS1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with QARS1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
GO Biological Process Annotations 2023 biological processes involving QARS1 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving QARS1 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2023 cellular components containing QARS1 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing QARS1 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by QARS1 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by QARS1 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of QARS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of QARS1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of QARS1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
KEGG Pathways 2026 pathways involving QARS1 protein from the KEGG Pathways 2026 dataset.
PFOCR Pathway Figure Associations 2023 pathways involving QARS1 protein from the PFOCR Pathway Figure Associations 2023 dataset.
Reactome Pathways 2024 pathways involving QARS1 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of QARS1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of QARS1 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of QARS1 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of QARS1 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of QARS1 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of QARS1 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of QARS1 gene from the Sci-Plex Drug Perturbation Signatures dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of QARS1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of QARS1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with QARS1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.